David Hallal
Patrimonio netto: 21 M $ in data 31/05/2026
Patrimonio netto: 21 M $ in data 31/05/2026
David L. Hallal è presidente e amministratore delegato di AlloVir, Inc., presidente di iTeos Therapeutics SA, presidente di iTeos Therapeutics, Inc., Lead Independent Director di Seer, Inc. (California), presidente e amministratore delegato di ElevateBio LLC, presidente di Scholar Rock, Inc. e presidente di Scholar Rock Holding Corp. Fa parte del Consiglio di amministrazione di Seer, Inc. (California) e della Pharmaceutical Research & Manufacturers of America. Hallal è stato precedentemente impiegato come amministratore delegato e direttore di Alexion Pharmaceuticals, Inc., vicepresidente delle vendite di (OSI) Eyetech, responsabile delle vendite di Biogen Idec, Inc., direttore delle vendite di oncologia sudorientale di Amgen, Inc. e direttore delle vendite nazionali di Eyetech Pharmaceuticals, Inc. Ha ricevuto la sua laurea presso l'Università del New Hampshire.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/04/2026 | 403.530 ( 0,35% ) | 20 M $ | 31/05/2026 | |
0,55% | 03/06/2026 | 130.554 ( 0,55% ) | 688 020 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Amministratore Delegato | 27/04/2025 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direttore/Membro del Consiglio | - |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Presidente | 06/07/2017 |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Presidente | 27/06/2018 |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines | Fondatore | 01/12/2017 |
LifeEDIT Therapeutics, Inc.
LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome editing and engineering services | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Presidente | 28/08/2025 |
| ALEXION PHARMACEUTICALS, INC. | Amministratore Delegato | 12/12/2016 |
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology Provides medical services | Vendite & Marketing | 01/06/2006 |
| ░░░░░░ ░░░░ | ░░░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology Provides medical services | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
AlloVir, Inc.
AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Seer, Inc. (California)
Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology Operates as biotechnology holding company, which develops gene therapy and manufactures & commercializes life-transforming medicines | Health Technology |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
LifeEDIT Therapeutics, Inc.
LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome editing and engineering services | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale